FDA Gives Greenlight to Janssen and AbbVie's Imbruvica for the 10th Time

FDA Gives Greenlight to Janssen and AbbVie's Imbruvica for the 10th Time

Submitted by admin on January 28, 2019 - 12:11pm
Source: 
BioSpace
News Tags: 
Imbruvica
Janssen
AbbVie
Roche
Gazyva
chronic lymphocytic leukemia
small lymphocytic lymphoma
FDA
Headline: 
FDA Gives Greenlight to Janssen and AbbVie's Imbruvica for the 10th Time
snippet: 

Imbruvica, in combination with Roche's Gazyva, was approved as the first chemotherapy-free treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma.

Do Not Allow Advertisers to Use My Personal information